The healthcare sector is prioritizing sustainable management solutions for lifelong genetic abnormalities, causing a substantial surge in focused drug delivery pipelines. Congenital adrenal hyperplasia, which stems primarily from 21-hydroxylase deficiency, leaves individuals highly dependent on perpetual pharmacological management to avoid adrenal crises. As medical systems modernize,...